Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Alejandro Sweet-Cordero

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Cancer Cell|July 13, 2013
A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewalYanyan Zheng, Cecile C de la Cruz, Leanne C Sayles, et al.
Science Translational Medicine|February 8, 2013
Blocking NRG1 and other ligand-mediated Her4 signaling enhances the magnitude and duration of the chemotherapeutic response of non-small cell lung cancerGanapati V Hegde, Cecile C de la Cruz, Cecilia Chiu, et al.
Nature Medicine|February 14, 2017
Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axisChen-Hua Chuang, Peyton G Greenside, Zoë N Rogers, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
STING activation reshapes the tumor microenvironment leading to tumor regression in osteosarcomaElizabeth P Young, Christine A Johnson, Alex G Lee, et al.
Oncotarget|May 19, 2016
Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse modelTsion Zewdu Minas, Didier Surdez, Tahereh Javaheri, et al.
Nature Communications|February 22, 2017
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancerAdrian Vallejo, Naiara Perurena, Elisabet Guruceaga, et al.
Pediatric Blood & Cancer|June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task ForceSarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Cancer|July 30, 2019
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology GroupRyan D Roberts, Michael M Lizardo, Damon R Reed, et al.
The Journal of Clinical Investigation|December 25, 2019
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreasKarmele Valencia, Oihane Erice, Kaja Kostyrko, et al.
Cancer Research|March 11, 2026
FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor TherapyDaniel E Gracilla, Shruti Menon, Marcus R Breese, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Cancer Cell|July 13, 2013
A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewalYanyan Zheng, Cecile C de la Cruz, Leanne C Sayles, et al.
Science Translational Medicine|February 8, 2013
Blocking NRG1 and other ligand-mediated Her4 signaling enhances the magnitude and duration of the chemotherapeutic response of non-small cell lung cancerGanapati V Hegde, Cecile C de la Cruz, Cecilia Chiu, et al.
Nature Medicine|February 14, 2017
Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axisChen-Hua Chuang, Peyton G Greenside, Zoë N Rogers, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
STING activation reshapes the tumor microenvironment leading to tumor regression in osteosarcomaElizabeth P Young, Christine A Johnson, Alex G Lee, et al.
Oncotarget|May 19, 2016
Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse modelTsion Zewdu Minas, Didier Surdez, Tahereh Javaheri, et al.
Nature Communications|February 22, 2017
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancerAdrian Vallejo, Naiara Perurena, Elisabet Guruceaga, et al.
Pediatric Blood & Cancer|June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task ForceSarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Cancer|July 30, 2019
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology GroupRyan D Roberts, Michael M Lizardo, Damon R Reed, et al.
The Journal of Clinical Investigation|December 25, 2019
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreasKarmele Valencia, Oihane Erice, Kaja Kostyrko, et al.
Cancer Research|March 11, 2026
FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor TherapyDaniel E Gracilla, Shruti Menon, Marcus R Breese, et al.
Pageof 7